Smokers’ metabolism of nicotine could point to the best way to quit The speed at which smokers metabolise nicotine may suggest the most effective smoking cessation method – either varenicline or the nicotine patch.…
Food supplement improves brain energy in Huntington disease, study suggests Patients with Huntington disease who were treated with the fatty acid food supplement triheptanoin oil experienced improved motor function.…
Malaria eradication: blocking transmission to mosquitoes To wipe out malaria, researchers are racing to develop a vaccine that protects mosquitoes from infection.…
Human trials of ‘prime and boost’ Ebola vaccine underway The University of Oxford has begun a phase I clinical trial of a preventive Ebola vaccine that uses a ‘prime and boost’ approach.…
Intensive glycaemic therapy for type 1 diabetes cuts risk of death Intensive glycaemic therapy for patients recently diagnosed with type 1 diabetes resulted in a decreased rate of long-term mortality compared with patients given conventional therapy.…
Interim results of stem cell treatment for multiple sclerosis show promise Stem cell treatment after high-dose immunosuppressive therapy could be an effective way to manage relapsing remitting multiple sclerosis.…
Oxygen therapy reduces dyspnoea in COPD patients with mild disease Continuous oxygen during exertion, but not short-burst therapy, significantly reduces dyspnoea in patients with mild chronic obstructive pulmonary disease, researchers find.…
Merton Sandler (1926-2014) Merton Sandler was fascinated by investigative medicine and was a passionate researcher, who would often use himself as a test subject.…
Carfilzomib gives survival benefits to patients with relapsed multiple myeloma Adding the proteasome inhibitor carfilzomib to lenalidomide plus dexamethasone, the standard treatment for patients with relapsed multiple myeloma, significantly improves outcomes.…
The European Medicines Agency still has a way to go towards clinical trial transparency Loopholes in the new policy on publishing clinical study reports from the European Medicines Agency need to be closed.…